Michael Rimmer (MB ChB (Hons), MRes, MSc, PhD, MRCOG)

Chief Scientific Officer Clinical Lecturer in Obstetrics and Gynaecology

  • Centre for Inflammation Research
  • Institute of Regeneration and Repair

Contact details

Address

Street

Centre for Inflammation Research
Institute for Regeneration and Repair
4-5 Little France Drive

City
Edinburgh
Post code
EH16 4UU

Background

I am a Clinical Lecturer and Specialist Registrar in Obstetrics and Gynaecology, undertaking sub-specialist training in Reproductive Medicine and Surgery based at the University of Edinburgh and NHS Lothian.

My current research focuses on extracellular vesicles as a source of biomarkers for disease detection, particularly in gynaecological cancer. I am interested in how these vesicles and their molecular cargo can be used to develop earlier, less invasive diagnostic approaches and improve translation of biomarker discovery into clinical practice as well as deriving greater mechanistic understanding as to how diseases develop. 

I completed an MRC Clinical Research Fellowship and PhD at the University of Edinburgh’s MRC Centre for Reproductive Health, where my work focused on male pre-pubertal oncofertility preservation and the role of extracellular vesicles in cellular responses to chemotherapy.

My wider academic interests span translational reproductive science, cancer biomarker discovery, and understanding how reproductive and gynaecological conditions influence fertility and long-term health outcomes.

Qualifications

MB ChB (Hons), MRes, MSc, PhD, MRCOG 

Open to PhD supervision enquiries?

Yes

Current PhD students supervised

Sofia Olendraru 

Current research interests

My research focuses on developing extracellular vesicles (EVs) as minimally invasive biomarkers for the earlier detection and monitoring of ovarian cancer. EVs are microscopic, membrane-bound particles released by cells into the bloodstream. They carry proteins and other molecular information from their cell of origin, making tumour-derived EVs a valuable “liquid biopsy” of ovarian cancer. Our interdisciplinary team uses advanced imaging techniques to detect and characterise EVs directly in blood samples. My research evaluates combinations of EV markers and ovarian cancer-associated markers for diagnostic potential and to understand their mechanistic roles in driving disease.